Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
2(22%)
Results Posted
25%(1 trials)

Phase Distribution

Ph not_applicable
5
56%
Ph phase_3
1
11%
Ph phase_4
2
22%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution8 total trials
Phase 3Large-scale testing
1(12.5%)
Phase 4Post-market surveillance
2(25.0%)
N/ANon-phased studies
5(62.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

4 of 6 finished

Non-Completion Rate

33.3%

2 ended early

Currently Active

2

trials recruiting

Total Trials

9

all time

Status Distribution
Active(3)
Completed(4)
Terminated(2)

Detailed Status

Completed4
Recruiting2
Withdrawn2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 31 (12.5%)
Phase 42 (25.0%)
N/A5 (62.5%)

Trials by Status

completed444%
recruiting222%
withdrawn222%
not_yet_recruiting111%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
9